NEXUS PHARMS FDA Approval ANDA 215290

ANDA 215290

NEXUS PHARMS

FDA Drug Application

Application #215290

Application Sponsors

ANDA 215290NEXUS PHARMS

Marketing Status

Prescription001

Application Products

001INJECTABLE;INJECTIONEQ 500MG BASE/VIAL0ERYTHROMYCIN LACTOBIONATEERYTHROMYCIN LACTOBIONATE

FDA Submissions

UNKNOWN; ORIG1AP2022-02-14STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAP

CDER Filings

NEXUS PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 215290
            [companyName] => NEXUS PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"ERYTHROMYCIN LACTOBIONATE","activeIngredients":"ERYTHROMYCIN LACTOBIONATE","strength":"EQ 500MG BASE\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"02\/14\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-02-14
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.